N4 Pharma Plc (LON:N4P – Get Free Report)’s stock price was up 9.1% on Monday . The company traded as high as GBX 0.60 ($0.01) and last traded at GBX 0.60 ($0.01). Approximately 361,191 shares changed hands during mid-day trading, a decline of 69% from the average daily volume of 1,154,701 shares. The stock had previously closed at GBX 0.55 ($0.01).
N4 Pharma Stock Down 2.7 %
The firm has a market cap of £2.11 million, a P/E ratio of -55.00 and a beta of -0.37. The firm’s 50 day moving average is GBX 0.63 and its two-hundred day moving average is GBX 0.57. The company has a current ratio of 22.73, a quick ratio of 7.28 and a debt-to-equity ratio of 1.62.
N4 Pharma Company Profile
N4 Pharma’s business model is to partner with companies developing novel antigens in these fields to use Nuvec® as the delivery vehicle for these antigens.
See Also
- Five stocks we like better than N4 Pharma
- Comparing and Trading High PE Ratio Stocks
- 3 Stocks Helping to Bring AI to Healthcare
- Canadian Penny Stocks: Can They Make You Rich?
- 3 Stocks Ringing in The New Year With Large Buyback Announcements
- Trading Halts Explained
- Why 2024 Was Great for Stocks—and Why 2025 Could Be Even Better
Receive News & Ratings for N4 Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for N4 Pharma and related companies with MarketBeat.com's FREE daily email newsletter.